Article
Bharat Biotech Seeks Approval For Phase 3 Trial Of Intranasal Shots As Boosters
Rating:
0.0
Views:
68
Likes:
1
Library:
1
Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its intranasal vaccine (BBV154) against Covid to be used as a booster dose, sources said on Monday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value